Home » Posts tagged 'vectorvest uk'
Tag Archives: vectorvest uk
VectorVest UK MD David Paul discusses UK and US market trends, VV ‘worry free’ and aggressive portfolio successes and upcoming London shows on Core Finance TV
VectorVest UK MD David Paul discusses UK and US short-term and longer term trends on Core Finance TV. UK market short-term and longer term trend both up whilst U.S. market short term trend down and longer trend up.
David also speaks on VV most conservative ‘worry free investing’ model portfolio, which for 2019 to date (8th March) is up 17%. Plus VV more aggressive portfolio, MT Prospects.
VectorVest provide both conservative portfolios for longer term hands off investors and more aggressive portfolios for short term swing traders.
Upcoming shows:
-
UK investor show in Westminster 30th of March
-
Master Investor Islington 6th of April
-
Seminar at Chesterfield hotel in Mayfair 13th of April
Buy iEnergizer #IBPO says VectorVest. The stock still has legs despite recent rise and stellar interim numbers
AIM listed iEnergizer Ltd, (IBPO.L) is a global provider of Business Process Outsourcing (BPO). Leading companies in the Healthcare, BFSI, Gaming, Publishing and Legal industries successfully outsource mission-critical business processes to the Company. With over 12,000 staff, IBPO builds and operates customized customer contact, back office and high-volume transaction processing centres serving the entire customer lifecycle, from outbound first contact to post-sales support and everything in-between.
On November 13th2018, IBPO reported a strong set of interim results, with a 9.5% increase in service revenues to $82.4m, EBITDA up 39.1% to $24.3m and an increase in EBITDA margin to 29.1% (H1 2018: 23.0%). Profit before tax increased to $21.0m from $12.1m previously, while net debt fell to $18.5m (31 March 2018: $26.4m). Chairman Marc Vassanelli said the performance “reflects the significant progress being made by colleagues across the Company, as we continue to focus on recurring revenue streams, as well as effectively offsetting pressure in the traditional publishing sector by capitalizing on our advantageous position to service existing and new customers’ needs in the evolving digital technology landscape“… adding.. “The Company’s healthy cash position, together with its cash generative business model, puts iEnergizer in a strong position to invest in both organic and inorganic growth opportunities in the periods ahead. We expect sustained business performance through the second half of the year and the Board looks forward to the remainder of the year with confidence.”
The VectorVest stock analysis and portfolio management platform flagged up the IBPO investment opportunity to members in August 2018. Although the stock has literally doubled in price since then, it still logs an excellent Relative Timing (RT) (stock price trend) rating of 1.48, (scale of 0.00 to 2.00) and a very good forecasted GRT (Earnings Growth Rate) of 16.00%. Less adventurous investors may be discouraged by the RS (Relative Safety) rating of 0.92, (again on a scale of 0.00 to 2.00), but trading at 120p, IBPO is still clearly undervalued against a current VectorVest valuation of 140.27p per share.
The chart of IBPO is shown above using weekly candlesticks over the past 3 years. The share is trending upwards strongly and is on a BUY recommendation on VectorVest. Earnings per Share (EPS) has risen strongly over the past two months while EPS has increased by 3 times over the 3-year period shown.
Summary: VectorVest members who bought into IBPO after the platform flagged up a clear valuation gap in August will have doubled the value of their holdings in the space of just a few months. Normally a period of consolidation occurs after such a rise, but IBPO still appears to have legs, thanks to a stellar set of interim numbers, strong cash position and bullish view for the second half of the financial year. The low RS reading may serve to discourage some investors, but the results, outlook and charting position all point to further near term growth. Buy.
Dr David Paul
November 29th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
David Paul of Vectorvest on Core Finance TV – Waiting for confirmation of a bottom in the Stock Market, plus #AAL, #RIO, #ELA, #PSON
Dr David Paul of Vectorvest appears with Nick ‘Moose” Batsford on Core Finance TV. Subject: Waiting for confirmation of a bottom in the Stock Market. Stocks covered include Anglo American (AAL), Rio Tinto (RIO), Eland Oil & Gas #ELA and Pearson #PSON. “Never let a good crisis go to waste”.
Brand CEO Alan Green talks PowerHouse Energy #PHE, Bloomsbury Publishing #BMY, Salt Lake Potash #SO4 & Vast Resources #VAST on Vox Markets podcast
Brand CEO Alan Green talks PowerHouse Energy #PHE, Bloomsbury Publishing #BMY, Salt Lake Potash #SO4 & Vast Resources #VAST with Justin Waite on the Vox Markets podcast. Interview is 9 minutes 40 seconds in.
Four mistakes preventing consistent market gains – VectorVest
Four mistakes preventing consistent market gains. You may not even be aware that you make these mistakes but they can absolutely affect your investing outcome. Which of these mistakes has cost you the most? How Much? David Paul of VectorVest discusses on Core Finance. Join VectorVest at the London Investor Show this coming Friday, 19th October, Novotel London West at Stand E9.
Buy FairFX Group (FFX.L) says VectorVest. This innovative financial challenger brand offers a compelling investment opportunity right now.
FairFX Group Plc (FFX.L) is a leading challenger brand in banking and payments that disintermediates the incumbent banks with a superior user experience and low cost operating model. This enables personal and business customers to make easy, low-cost multi-currency payments in a broad range of currencies and across a range of FX products all via one integrated system. Banking and payment services to both personal and business customers are made through four channels: Currency Cards, Physical Currency, International Payments and Bank Accounts. The FairFX platform facilitates payments either direct to Bank Accounts or at 30 million merchants and over 1 million ATM’s in a broad range of countries globally via Mobile apps, the Internet, SMS, wire transfer and MasterCard/VISA debit cards.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On July 6th2018, FFX published a trading statement for the six-month period ended 30thJune 2018. The Company reported a strong first half of trading, with substantial growth and new products launched. Against this background, strong margins have been maintained and rationalisation of the supply chain is delivering results. Including contributions from newly acquired Cardone Banking and City Forex, FFX reported a 146% increase in turnover for the year on year period to £1.1bn (2017: £434.1 million), in line with management’s expectations. The strong first half gives the Board confidence that the Company will achieve market expectations for the full financial year. CEO Ian Strafford-Taylor said the fact that the substantial growth in turnover has been achieved without reduced margins “gives us great confidence for the prospects for 2018 and beyond.”
The impressive progress by FFX since Feb 2018 did not go unnoticed by VectorVest. A Relative Value flag (RV is an indicator of long-term price appreciation) had originally alerted members back as far as Sept 2017, as the level moved above 1. The FFX RV has remained well above 1 since that time, and today logs the stock at 1.71, which is both exceptional and excellent on a scale of 0.0 – 2.0. Other leading metrics on the VectorVest stock and portfolio management system include a GRT (Earnings Growth Rate) of 48%, again both exceptional and excellent, along with a good RS (Relative Safety) rating of 1.12, also on a scale of 0.0 – 2.0. Even so, trading today at 138p, FFX is still some way below the current VectorVest valuation of 183p.
The chart of FFX is shown above in my normal format. The green line study above the price is the VectorVest valuation while Earnings per share is reflected by the blue line study in the window below the price. Technically the share is trending higher but currently “coiling” within a symmetrical triangle. A breakout of the upper trendline defining the triangle should lead to a strong move upwards.
Summary: FFX already dominates what is a highly competitive space with its secure low cost, multi-currency payment solutions. Eagle eyed VectorVest members who spotted this opportunity back in September last year will already have seen their investment double in value, but as the fundamentals and charting configuration indicate today, there is a great deal more growth to come. FFX stated that H2 is about extracting efficiencies via scale, evolving banking products for SME’s and continuing to identify and maximise cross-selling opportunities. On the evidence presented today, this innovative financial services challenger brand will continue to deliver growth with this strategy, and in the opinion of VectorVest, offers a compelling investment opportunity right now. Buy.
Dr David Paul
September 26th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy Benchmark Holdings #BMK says VectorVest. There is every sign that the company is developing into a highly investible proposition.
UK based Benchmark Holdings (BMK.L) challenges the status quo in aquaculture. Since 2000, BMK has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services, to serve its customers, helping them to improve yield and efficiency in a sustainable way. The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. BMK operates in 27 countries globally and employs 950 people.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On June 19th2018, BMK published interim results for the six months ended 31 March 2018. The Company reported a 91% increase in adjusted EBITDA to £6.3m on revenues 9% higher at £75.7m. An £8.2m loss for the same period last year turned into a £3.6m profit, driven by improved trading, a reduction in finance costs and a £9.2m tax credit resulting from a reduced deferred tax liability on intangibles from the acquisition of INVE. CEO Malcolm Pye said the results showed “good organic revenue growth and improving profitability on an adjusted basis, while we continue to invest in our pipeline of new products and infrastructure.” “The outlook for the Group is positive as the drivers for our business are stronger than ever before, with continued growth in aquaculture and increasing recognition from consumers, producers and regulators of the need for sustainable solutions to enable future growth.”Separately on Sept 10th2018 BMK announced the commencement of production of salmon eggs at its new land based breeding facility in Salten, Norway. The centre is the World’s most advanced egg facility, and increases Benchmark’s capacity by 75%.
Since the end of May 2018, BMK has consistently flagged a high Relative Value (RV) reading to VectorVest members. The RV metric is an indicator of long-term price appreciation potential, and even today continues to log BMK at 1.47, excellent on a scale of 0.0 – 2.0. Added to this the company logs a GRT (Earnings Growth Rate) of 32%, which also rates as excellent on the VectorVest stock and portfolio management system. Cautious investors may decide to look elsewhere given that BMK offers a ‘fair’ RS (Relative Safety) rating of 1.00, again on a scale of 0.00 to 2.00, but trading today at 62p, BMK still offers plenty of upside against a current VectorVest valuation of 81p.
The chart of BMK.L is shown above using weekly candlesticks. The share is undervalued and has recently broken upwards from a five-wave symmetrical triangle of two years duration. The first technical target from the triangle breakout is around 100p.
Summary: VectorVest has this week identified another niche sector operator, with leading positions in core aquaculture markets around the globe. This acquisitive operator has completed several notable acquisitions in the past few years, and significantly in the first half turned a loss into a profit on higher revenues. While the low RS metric may deter the more cautious investor, there is every sign that BMK is developing into a highly investible proposition given its global footprint, not to mention the opening of the World’s most advanced salmon egg facility and consequential increase in capacity. Coupled with the recent bullish charting signals, VectorVest recommends the stock as a buy
Dr David Paul
September 19th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy Hastings Group Holdings #HSTG says VectorVest. Strong interim results and improved fundamentals provide platform for further growth
Founded in 1996 in Bexhill-on-Sea on the Sussex coast, Hastings Group (HSTG.L) is one of the fastest growing general insurance providers to the UK market, with 2.7m live customer policies and employing over 3,400 colleagues at sites in Bexhill, Leicester, Gibraltar and London. The group, which also trades via ‘Hastings Premier’, ‘Hastings Essential’, ‘Hastings Direct SmartMiles’, ‘People’s Choice’ and ‘insurePink’, provides straightforward products and services to UK car, bike, van and home insurance customers with around 90% of policies directly underwritten by its Gibraltar based insurer, Advantage Insurance Company Limited. The Group operates as an integrated insurance provider with two businesses. The Group’s Retail business, Hastings Insurance Services Limited, is responsible for the end customer pricing, fraud management, product design, distribution and management of the underlying customer relationships. The Group’s Underwriting business, Advantage Insurance Company Limited, engages in risk selection, underlying technical pricing, reserving and claims handling.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On August 8th 2018, HSTG published interim results for the six months ended 30 June 2018. HSTG reported a 9% increase in net revenue to £376.3m, with strong growth in adjusted operating profit, up 22% to £105.1m after including £14.6m of prior year VAT recovery and a £7m impact from adverse weather in Q1. HSTG reported sustained growth (up 6%) of live customer policies to 2.7m, which resulted in an increase in share of the UK private car insurance market to 7.5% from 7% previously. Significantly the group also reported a strong solvency position, with a Solvency II coverage ratio of 171%, up from 167% at 31 Dec 2017, a significant increase in free cash generated, up £42.0m to £107.8m for the period and a 10% increase in the interim dividend to 4.5p per share. CEO Toby van der Meer said the group’s strong financial position and continuing cash generation “means we remain on track to meet all our 2019 targets and I would like to thank my 3,400 colleagues for what they do for our customers and each other, every day. It is their hard work, passion and commitment that has achieved a set of results that we can all be proud of.”
VectorVest metrics flagged up the progress of this stock to members as the key RT (Relative Timing) metric ticked up over 1 in early May 2018. The HSTG share price and RT metric fell back from that point and bottomed out at year lows around 229p in July, but subsequently both share price and RT metric moved sharply higher. Today, the HSTG RT metric, (a fast, smart indicator of a stock price trend) logs the stock at 1.29 – very good on a scale of 0.00 to 2.00, but the RV (Relative Value) metric, (an indicator of long-term price appreciation potential) logs HSTG as excellent at 1.42 (also on a scale of 0.00 to 2.00). The stock continues to register an excellent GRT (Earnings Growth Rate) rating of 20%, but still offers considerable scope for further upside trading at 270p against a current VectorVest valuation of 367p.
A weekly chart of Hastings is shown above. After a strong upmove the share retraced to 78% of that move. The latter is a support level used by Fibonacci orientated traders. From this level after a two-month period of accumulation the share price has advanced and is currently on a VectorVest Buy signal. The major reverse divergence also known as a “slingshot” between the price and the MACD indicator is very positive for a further upside move when the mood of the overall market improves.
Summary: Motor and general insurance is an incredibly competitive and fast-moving industry, where market leaders have to continually evolve, while at the same time retaining careful cost controls. With its broad product portfolio, HSTG is arguably one of the finest exponents of this particular art, as demonstrated by the strong set of interim results. Of particular note is the strong solvency position and free cash generation, essential components for growth, that no doubt give the group CEO his clearly stated confidence in the full year outcome. Given the disparity between the current share price and target, supported by a bullish chart, VectorVest recommends the shares as a buy.
Dr David Paul
September 5th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Reiterate buy Taptica #TAP says VectorVest. More growth to come from this dynamic technology company.
AIM listed Taptica International (TAP.L) is a global leader in advertising technologies that operates in more than 70 countries. It has two revenue streams: performance-based marketing, provided by its Taptica business, and brand advertising, provided by its Tremor Video DSP business. The Taptica business is an end-to-end mobile technology advertising platform that helps the world’s top brands reach their most valuable users with the widest range of traffic sources available today. Tremor Video DSP is the leading programmatic video platform, matching advertisers with audiences -wherever they may be. The Company works with more than 600 advertisers including Amazon, Disney, Twitter, OpenTable, Expedia and Zynga. Taptica is headquartered in Israel with offices in San Francisco, New York, Tokyo, Beijing, Seoul and London.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On Sept 4th 2018, TAP published interim results for the six months ended 30 June 2018. Revenue increased by 119.4% to $144m, with gross profit 126.4% higher at $58.5m and a 40.6% improvement in gross margin. The Company also paid an interim dividend of $0.0398 per share, and following a $30m fundraise, net cash at 30 June 2018 stood at $42.1m (31 Dec: net debt of $4m). CEO Hagai Tal said that adding household brands such as GlaxoSmithKline and Whole Foods to the list of Tier 1 clients at Tremor “demonstrates good growth in our performance-based business unit reflecting the successful execution on our strategy to expand into new geographies.” He added that TAP expects sustained improvement in margins through increased operational efficiencies, economies of scale and technology enhancements. “As a result, we expect EBITDA for full year 2018 to be ahead of market expectations.”
VectorVest highlighted the potential of TAP in two blog entries on the 21st March and 11thJuly 2017. At that stage the share was trading at 295p. TAP shares have consistently flagged excellent RV metric readings since that time, (RV is indicator of long-term price appreciation potential), and today logs at 1.4, which is excellent on a scale of 0.00 to 2.00. The key RT (Relative Timing) metric, (a fast, smart indicator of a stock price trend) also logs at 1.29, which is rated by VectorVest as very good on a scale of 0.00 to 2.00, and this is coupled with a GRT (Earnings Growth Rate) metric of 20%, also very good. Today TAP shares have moved higher to trade at 360p, but despite this, the stock is still some way below the latest VectorVest valuation of 504p.
A weekly chart of TAP.L is shown above since the listing. The share retraced during the first four months of 2018 to 78% from the listing to January 2018. The retracement occurred in 3 waves which FIB orientated traders consider a corrective waveform within an overall bullish scenario. The share has charted a treble bottom at the very important FIB level and looks set for further gains and an attack on the highs made in January 2018.
Summary: In our comments last year, we noted that TAP was ‘in serious growth mode’ despite having already delivered spectacular returns for its early stage shareholders. Since that time, TAP has raised additional funds for a warchest, delivered impressive growth in revenue and profits and paid a dividend. Some may now take the view that the major period of growth is over, but comments from the CEO and a bullish charting picture indicate otherwise. VectorVest believes there is a lot more to come from this dynamic technology company. Buy.
Dr David Paul
September 5th 2018
Readers can examine trading opportunities on this and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 30-day trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com